Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 7
Submit an article Journal homepage
377
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Frequency and clinical implications of SOX11 expression in Burkitt lymphoma

Tove WästerlidDepartment of Oncology, Lund University, Skåne University Hospital, Lund, Sweden; Correspondence[email protected]
,
Lena NordströmDepartment of Immunotechnology, CREATE Health, Lund University, Lund, Sweden;
,
Catja FreiburghausDepartment of Immunotechnology, CREATE Health, Lund University, Lund, Sweden;
,
Mette PedersenDepartment of Pathology, Copenhagen University Hospital, Herlev, Denmark;
,
Peter NørgaardDepartment of Pathology, Copenhagen University Hospital, Herlev, Denmark;
,
Anne O. GangDepartment of Hematology, Copenhagen University Hospital, Herlev, Denmark;
,
Peter BrownDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark;
,
Michael DictorDepartment of Pathology, Skåne University Hospital, Lund, Sweden
,
Mats JerkemanDepartment of Oncology, Lund University, Skåne University Hospital, Lund, Sweden;
&
Sara EkDepartment of Immunotechnology, CREATE Health, Lund University, Lund, Sweden;
show all
Pages 1760-1763 | Received 23 Aug 2016, Accepted 04 Nov 2016, Published online: 21 Nov 2016

References

  • Sock E, Rettig SD, Enderich J, et al. Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Mol Cell Biol. 2004;24:6635–6644.
  • Sernbo S, Gustavsson E, Brennan DJ, et al. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. BMC Cancer. 2011;11:405.
  • Liu DT, Peng Z, Han JY, et al. Clinical and prognostic significance of SOX11 in breast cancer. Asian Pac J Cancer Prev. 2014;15:5483–5486.
  • Mozos A, Royo C, Hartmann E, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009;94:1555–1562.
  • Nordstrom L, Sernbo S, Eden P, et al. SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study. Br J Haematol. 2014;166:98–108.
  • Nygren L, Baumgartner Wennerholm S, Klimkowska M, et al. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood. 2012;119:4215–4223.
  • Palomero J, Vegliante MC, Rodriguez ML, et al. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma. Blood. 2014;124:2235–2247.
  • Vegliante MC, Palomero J, Perez-Galan P, et al. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma. Blood. 2013;121:2175–2185.
  • Kuo PY, Leshchenko VV, Fazzari MJ, et al. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma. Oncogene. 2015;34:1231–1240.
  • Roisman A, Stanganelli C, Nagore VP, et al. SOX11 expression in chronic lymphocytic leukemia correlates with adverse prognostic markers. Tumour Biol. 2015;36:4433–4440.
  • Dictor M, Ek S, Sundberg M, et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt’s lymphoma. Haematologica. 2009;94:1563–1568.
  • Wästerlid T, Brown PN, Hagberg O, et al. Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. Ann Oncol. 2013;24:1879–1886.
  • Nordstrom L, Andreasson U, Jerkeman M, et al. Expanded clinical and experimental use of SOX11 – using a monoclonal antibody. BMC Cancer. 2012;12:269
  • Gustavsson E, Sernbo S, Andersson E, et al. SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol Cancer. 2010;9:187.
  • Masque-Soler N, Szczepanowski M, Kohler CW, et al. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2 – an analysis including gene expression in formalin-fixed paraffin-embedded tissue. Br J Haematol. 2015;171:501–508.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.